Clozapine interaction with the M2 and M4 subtypes of muscarinic receptors

European Journal of Pharmacology

Volumn 376, Issue 1-2, 1999, Pages 119-125

  Michal, Pavel ^a   Lysíková, Michaela ^a   El Fakahany, Esam E ^b   Tuček, Stanislav ^a  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

cAMP; Clozapine; Muscarinic receptor

Indexed keywords

ATROPINE; CARBACHOL; CLOZAPINE; CYCLIC AMP; METHYLSCOPOLAMINE; MUSCARINIC M2 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC RECEPTOR; RECEPTOR SUBTYPE; LIGAND; MUSCARINIC AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT;

ALLOSTERISM; ANIMAL CELL; ARTICLE; BINDING SITE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISSOCIATION; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; ANIMAL; BIOSYNTHESIS; CHO CELL; DRUG ANTAGONISM; DRUG EFFECT; HAMSTER; METABOLISM;

ALLOSTERIC REGULATION; ANIMALS; ANTIPSYCHOTIC AGENTS; CARBACHOL; CHO CELLS; CLOZAPINE; CRICETINAE; CYCLIC AMP; LIGANDS; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; N-METHYLSCOPOLAMINE; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M4; RECEPTORS, MUSCARINIC;

EID: 0032586794     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00341-6     Document Type: Article

References (31)

1. Arunlakshana O., Schild H.O. Some quantitative uses of drug antagonists. Br. J. Pharmacol. 14:1959;48-58.
2. Ashby C.R., Wang R.Y. Pharmacological actions of the atypical antipsychotic drug clozapine: a review. Synapse. 24:1996;349-394.
3. Baldessarini R.J., Frankenburg F.R. Clozapine. A novel antipsychotic agent. N. Engl. J. Med. 324:1991;746-754.
4. Bolden C., Cusack B., Richelson E. Clozapine is a potent and selective muscarinic antagonist at the five cloned human muscarinic acetylcholine receptors expressed in CHO-K1 cells. Eur. J. Pharmacol. 192:1991;205-206.
5. Bolden C., Cusack B., Richelson E. Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells. J. Pharmacol. Exp. Ther. 260:1992;576-580.
6. Buckley N.J., Bonner T.I., Buckley C.M., Brann M.R. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol. Pharmacol. 35:1989;469-476.
7. Bymaster F.P., Calligaro D.O., Falcone J.F., Marsh R.D., Moore N.A., Tye N.C., Seeman P., Wong D.T. Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology. 14:1996;87-96.
8. Caulfield M.P. Muscarinic receptors - characterization, coupling and function. Pharmacol. Ther. 58:1993;319-379.
9. Christopoulos A., Lanzafame A. Allosteric interactions at muscarinic cholinoceptors. Clin. Exp. Pharmacol. Physiol. 25:1998;185-194.
10. Ehlert F.J. Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods. Mol. Pharmacol. 33:1988;187-194.
11. o in reconstituted phospholipid vesicles. J. Biol. Chem. 264:1989;3909-3915.
12. S. Mol. Pharmacol. 41:1992;889-893.
13. o). J. Biol. Chem. 261:1986;10133-10140.
14. Holzgrabe U., Mohr K. Allosteric modulators of ligand binding to muscarinic acetylcholine receptors. Drug Discovery Today. 3:1998;214-222.
15. Jakubík J., Bačáková L., El-Fakahany E.E., Tuček S. Constitutive activity of the M1-M4 subtypes of muscarinic receptors in transfected CHO cells and of muscarinic receptors in the heart cells revealed by negative antagonists. FEBS Lett. 18:1995;275-279.
16. Jakubík J., Bačáková L., El-Fakahany E.E., Tuček S. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 274:1995;1077-1083.
17. 2-adrenergic receptors. Proc. Natl. Acad. Sci. U.S.A. 90:1993;10798-10802.
18. Matesic D.F., Manning D.R., Wolfe B.B., Luthin G.R. Pharmacological and biochemical characterization of complexes of muscarinic acetylcholine receptor and guanine nucleotide-binding protein. J. Biol. Chem. 264:1989;21638-21645.
19. McKinney M., Miller J.H., Gibson V.A., Nickelson L., Aksoy S. Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition. Mol. Pharmacol. 40:1991;1014-1022.
20. Miller R.J., Hiley C.R. Antimuscarinic properties of neuroleptics and drug induced parkinsonism. Nature. 248:1974;596-597.
21. Nordin C., Almé B., Bondesson U. CSF and serum concentrations of clozapine and its demethyl metabolite: a pilot study. Psychopharmacology. 122:1995;104-107.
22. 2, and 5-HT receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients. Am. J. Psychiatry. 152:1995;1444-1449.
23. Olianas M.C., Maullu C., Onali P. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptors. Br. J. Pharmacol. 122:1997;401-408.
24. Perry P.J., Miller D.D., Arndt S.V., Cadoret R.J. Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients. Am. J. Psychiatry. 148:1991;231-235.
25. Richelson E., Nelson A. Antagonism by neuroleptics of neurotransmitter receptor of normal human brain in vitro. Eur. J. Pharmacol. 103:1984;197-204.
26. Rinken A. Formation of the functional complexes of m2 muscarinic acetylcholine receptors with GTP-binding regulatory proteins in solution. J. Biochem. 120:1996;193-200.
27. Snyder S.H., Greenberg D., Yamamura H.I. Antischizophrenic drugs and brain cholinergic receptors: affinity for muscarinic sites predicts extrapyramidal effects. Arch. Gen. Psychiatry. 31:1974;58-61.
28. Stockton J.M., Birdsall N.J.M., Burgen A.S.V., Hulme E.C. Modification of the binding properties of muscarinic receptors by gallamine. Mol. Pharmacol. 23:1983;551-557.
29. Tuček S., Proška J. Allosteric modulation of muscarinic acetylcholine receptors. Trends Pharmacol. Sci. 16:1995;205-212.
30. Zeng X.P., Le F., Richelson E. Muscarinic m4 receptor activation by some atypical antipsychotic drugs. Eur. J. Pharmacol. 321:1997;349-354.
31. 4 receptor agonist. Eur. J. Pharmacol. 269:1994;R1-R2.